Table 1 The demographics of individuals enrolled in the study

From: Impact of ageing on homologous and human-coronavirus-reactive antibodies after SARS-CoV-2 vaccination or infection

 

Vaccinees

Patients

All

<80 years old

≥80 years old

All

No. of subjects

80

25

55

29c

Sex, M/F

32/48

9/16

23/32

14/15

Median age, years (range)

83 (27–98)

39 (27–63)

85 (80–98)

61 (24–84)

Comorbiditya (%)

48 (60)

1 (4)

47 (85)

19 (66)

Immunosuppressionb (%)

10 (13)

0 (0)

10 (18)

13 (45)

  1. aComorbidities include chronic heart disease, chronic lung disease, chronic liver disease, chronic kidney disease, diabetes, cancer, rheumatic disease, neurological disease, and autoimmune disease.
  2. bInherent immunosuppressive disease, HIV, organ transplant, chemotherapy, Prednisone or other immunosuppressive medication.
  3. cFive subjects at 12 months were excluded due to vaccination or sample missing, n = 24 at 12 months.
Back to article page